Kidney Disease News and Research

RSS

MIIR partners with international biosciences to develop potential anti-cancer drugs

The Marshall Institute for Interdisciplinary Research (MIIR) and the Marshall University Joan C. Edwards School of Medicine today announced they will be partnering with an international biosciences company to develop potential anti-cancer drugs.

11 Jul 2014

Fecal transplantation safe, effective for treating C. difficile in immunocompromised patients

Researchers have found that fecal transplantation is effective and safe for treating C. difficile in immunocompromised patients. This is the result of a study led by Colleen Kelly, M.D., a gastroenterologist in the Center for Women's Gastrointestinal Medicine at The Women's Medicine Collaborative.

10 Jul 2014

Study: Older kidney donors enjoy similar longevity, cardiovascular health as other healthy individuals

Older kidney donors enjoy similar longevity and cardiovascular health as other healthy mature individuals, according to a new study published in the American Journal of Transplantation.

9 Jul 2014

Fabry disease awareness: an interview with Dr. Hartmann Wellhoefer, Head of Medical Affairs, Rare Disease, Shire

Lysosomes are subcellular organelles that are present in most cells, with the major exception of red blood cells.

8 Jul 2014

ASN Foundation for Kidney Research provides $2.8 million to improve care for kidney patients

The American Society of Nephrology and the ASN Foundation for Kidney Research will fund $2.8 million in original, meritorious research in 2014 to improve care for the more than 20 million Americans with kidney disease, and for kidney patients worldwide.

8 Jul 2014

Medicare proposes to slightly raise kidney care payments

The CMS is proposing changes to payment policies for the treatment of end-stage renal disease that the agency estimates would increase payments by about 0.3 percent, or $30 million, in 2015.

4 Jul 2014

Acute kidney injury and chronic kidney disease are interconnected, say GW researchers

For more than 40 years, physicians have treated diminished kidney function as two distinct syndromes: acute kidney injury (AKI) and chronic kidney disease (CKD). However, recent epidemiologic and mechanistic studies suggest the two syndromes are not distinct entities, but interconnected.

4 Jul 2014

NEI researchers describe functions of gene responsible for anchoring cilia

Researchers at the National Eye Institute (NEI) have described the functions of a gene responsible for anchoring cilia - sensory hair-like extensions present on almost every cell of the body.

2 Jul 2014

Use of catheter ablation lowers risk for atrial fibrillation

Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits - both inpatient and emergency - and lower the risk for atrial fibrillation, according to research by UC San Francisco.

1 Jul 2014

New data analysis technique improves monitoring of kidney patients

A new data analysis technique radically improves monitoring of kidney patients, according to a University of Leeds-led study, and could lead to profound changes in the way we understand our health.

28 Jun 2014

Improved physical fitness reduces risk of CKD in patients with Type 2 diabetes

Adults with Type 2 diabetes who improve their physical fitness lower their chances of getting chronic kidney disease (CKD), and if they already have kidney damage, they can improve their kidney function.

24 Jun 2014

UC Irvine Health to use $3.4 million NIH grant to examine "Transition of Care in CKD"

UC Irvine Health will use a $3.4 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to examine the "Transition of Care in Chronic Kidney Disease (CKD)."

19 Jun 2014

Kareo and Falcon HER help nephrology practices leverage cloud-based technology

Kareo Inc., the leading cloud-based medical office software and services provider for small medical practices, today announced the launch of a new cooperative relationship with Falcon EHR, a division of DaVita HealthCare Partners Inc..

17 Jun 2014

New technique to uncover building blocks of kidney regeneration

Doctors and scientists have for years been astonished to observe patients with kidney disease experiencing renal regeneration. The kidney, unlike its neighbor the liver, was universally understood to be a static organ once it had fully developed.

17 Jun 2014

Otsuka Pharmaceutical begins tolvaptan Phase 3b study in patients with ADPKD

Otsuka Pharmaceutical Development & Commercialization, Inc., announced today that patient enrollment has begun for a new Phase 3b study of tolvaptan for adult patients with autosomal dominant polycystic kidney disease (ADPKD), the most common, life-threatening, inherited genetic kidney disorder.

11 Jun 2014

Diabetes Collaborative Registry aims at improving quality of diabetes across specialty care continuum

The American College of Cardiology, in partnership with the American Diabetes Association, the American College of Physicians and Joslin Diabetes Center, is launching the Diabetes Collaborative Registry, the first clinical registry aimed at tracking and improving the quality of diabetes and cardiometabolic care across the primary and specialty care continuum.

11 Jun 2014

Aetna partners with Fresenius Medical Care to improve lives of people with end stage renal disease

Fresenius Medical Care announced today a collaborative care model designed to improve the quality of care for Aetna's Medicare Advantage members who have end stage renal disease, while lowering health care costs.

10 Jun 2014

Improved glycemic control can slow progression of ESRD in type 1 diabetic people

People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.

6 Jun 2014

New therapies for kidney disease can be developed by revising definition of kidney disease

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that new therapies for kidney disease could be developed more quickly by revising the definition of kidney disease progression used during clinical trials.

4 Jun 2014

Thrasos presents positive results of THR-184 compound for treatment of acute kidney injury

Thrasos Therapeutics, a biotherapeutics company focused on delivering new solutions for kidney disease, today presented preclinical results showing that its lead development compound THR-184 can effectively protect against loss of kidney function following acute ischemic injury in rat.